Journal
/
Biologie du développement
/
Uso de transplante de células-tronco hematopoiéticas para avaliar a origem da síndrome mielodisplásica
Journal JoVE
Biologie du développement
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Biologie du développement
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Uso de transplante de células-tronco hematopoiéticas para avaliar a origem da síndrome mielodisplásica

9,681 Views

•

06:39 min

•

October 03, 2018

DOI:

10.3791/58140-v

DOI:
10.3791/58140-v

•

06:39 min
October 03, 2018

•

7 Views
, , ,
1Genetics Branch,Center for Cancer Research, National Cancer Institute, National Institutes of Health, 2LGI Flow Cytometry Core Facility,Center for Cancer Research, National Cancer Institute, National Institutes of Health

Summary

Automatically generated

Nós descrevemos o uso do transplante de células-tronco hematopoéticas (TCTH) para avaliar o potencial maligno das células hematopoiéticas geneticamente modificados. TCTH é útil para avaliar várias células hematopoiéticas malignas na vivo , bem como gerar uma grande coorte de ratos com Síndromes Mielodisplásicas (MDS) ou leucemia para avaliar novas terapias.

Explore More Videos

Hematopoietic Stem Cell TransplantationMyelodysplastic SyndromeCancer Stem CellsFunctional AnalysisDisease Initiating CellsAdoptive TransferTotal Body IrradiationBone Marrow Nucleated CellsFlow SortingBiotinylated Anti-lineage AntibodyAPC Conjugated Anti-Sca1 Antibody

Read Article

Cite this Article

Chung, Y. J., Khawaja, G., Wolcott, K. M., Aplan, P. D. Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome. J. Vis. Exp. (140), e58140, doi:10.3791/58140 (2018).

Download .ris file

Copy

Share Video

.

Copy